Canada Life’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Canada Life’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,941	Closed	-$210K	–	2570
2016 Q1	$210K	Hold	3,941	–	–	﹤0.01%	1288
2015 Q4	$445K	Hold	3,941	–	–	﹤0.01%	935
2015 Q3	$465K	Sell	3,941 -784	-17%	-$102K	﹤0.01%	901
2015 Q2	$365K	Hold	4,725	–	–	﹤0.01%	1088
2015 Q1	$268K	Hold	4,725	–	–	﹤0.01%	1199
2014 Q4	$151K	Hold	4,725	–	–	﹤0.01%	1471
2014 Q3	$113K	Buy	4,725 +3,941	+503%	+$80.1K	﹤0.01%	1595
2014 Q2	$11K	Hold	784	–	–	﹤0.01%	2308
2014 Q1	$15K	Hold	784	–	–	﹤0.01%	2175
2013 Q4	$11K	Hold	784	–	–	﹤0.01%	2200
2013 Q3	$8K	Buy	+784	New	+$6.86K	﹤0.01%	1120

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Canada Life's ANAC Position: Q2 2016 in Review

Canada Life sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 3,941 shares — an estimated $210K sold.

Canada Life first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $465K in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Canada Life reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Canada Life sold 3,941 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $210K.
Canada Life first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
Canada Life's ANACOR PHARMACEUTICALS INC COM position peaked at $465K in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Canada Life's 13F filing for Q2 2016, filed 3 Aug 2016.